| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |